Health
NHS set to pilot GRAIL’s wide-ranging cancer blood test – PMLiVE
Previous study indicates test can detect over 50 cancer types
The UK’s National Health Service (NHS) has signed a deal with healthcare company GRAIL to pilot its novel cancer blood test in 165,000 patients.
The Galleri blood test will be offered to 165,000 patients by NHS England in a new programme aimed at detecting early stage cancers.
The blood test identifies signs of a range of cancer types by searching for small fragments of DNA and RNA from tumours in the bloodstream to determine the presence of cancer.
The NHS will identify programme participants…
-
Noosa News19 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News17 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News15 hours agoFranz Ferdinand: Australian Tour 2025
-
General16 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win